Iris Isufi, MD

Assistant Professor of Medicine (Hematology)

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Hematology Program

Hematology

Transplantation Center, Yale-New Haven

Yale Medical Group

Board Certifications

  • Medical Oncology AB of Internal Medicine (2011)

  • Internal Medicine AB of Internal Medicine (2007)

Clinical Trials

Conditions Study Title
Non-Hodgkin's Lymphoma A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Leukemia, other A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (≥65 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
Lymphoid Leukemia E1912: A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Edit this profile

Contact Info

Iris Isufi, MD
Patient Care Location
Yale Cancer CenterYale-New Haven Hospital
20 York Street, Ste North Pavilion 7

New Haven, CT 06510
Mailing Address
333 Cedar Street FMP 130
PO Box 208032

New Haven, CT 06520-8032